Inspire Medical (INSP) news
Recent news
Trace Medical Q2 revenue USD 45.376 million vs. IBES estimate USD 44 million
Inspire Medical Systems (INSP) reported second-quarter revenue of $200.58 million, surpassing the Zacks Consensus Estimate of $197.63 million by 2.95%. This represents a decline compared to the same period in 2025, when the company generated $217.09 million in revenue. Despite the year-over-year…
AInvest Wire · Aug 7, 2026Inspire Medical Systems Inc: Truist Securities raises target price to $62 from $54
Truist Securities has raised its price target for Inspire Medical Systems Inc. (NYSE: INSP) to $62 from $54, maintaining a "Hold" rating on the stock . This adjustment reflects the firm’s updated assessment of the company’s financial performance and strategic outlook. Inspire Medical Systems, a…
AInvest Wire · Aug 4, 2026Inspire Medical Systems Inc: Stifel raises target price to $75 from $65
Stifel analyst Jonathan Block has raised his price target for Inspire Medical Systems Inc (NYSE: INSP) to $75 from $65, following the company’s Q1 2026 earnings release and subsequent guidance update. Despite Inspire’s full-year 2026 revenue outlook being cut to a range of $825 million to $875…
AInvest Wire · Aug 4, 2026Inspire Medical Systems Inc: Mizuho raises target price to $65 from $55
AInvest Wire · Aug 4, 2026Inspire Medical Systems Inc FY2026 SHR view $0.38, rev view $843.4 mln - LSEG IBES data
AInvest Wire · Aug 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.